integralife.com - IART Profit before deduction of interest, taxes, depreciation and amortization
Integra LifeSciences is implementing energy-saving standards and reducing plastic in its packaging. The issuer's revenues rely on clinic budgets and the rigor of medical oversight. The EBITDA_Co level on this chart demonstrates the cash dynamics of profit, where the value of 345.39 characterizes this level. Growth in indicators is supported by the robotization of neurosurgical production and the implementation of AI for sterility control.
Summary analytical data breakdowns for Integra LifeSciences Holdings Corporation (IART)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Integra LifeSciences|IART - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Integra LifeSciences Corp|IART - Company Aggregate Debts|Debts to Book Value Integra LifeSciences|IART - Company Long-Term Debts|Company Short-Term Indebtedness Integra LifeSciences|Interim Coverage Ratio integralife.com
- earnings and market multiples details:
IART - Net Profit|Future Profit Integra LifeSciences|IART - P/E Multiple|Forward P/E Multiple integralife.com|IART - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Integra LifeSciences|IART - Operating profit before deduction of amortization|Earnings per share for the trailing year Integra LifeSciences|IART - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months integralife.com|IART - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Integra LifeSciences
Summary company analytics:Integra LifeSciences
This indicator serves as the foundation for assessing the issuer's solvency and operational resilience. The metric aggregates net cash flow from core operations, excluding the impact of taxes, interest, and depreciation. Analyzing the EBITDA of Integra LifeSciences (IART) allows for the tracking of real-time profit dynamics. The stability of this trend is supported by inelastic demand for Integra LifeSciences neurosurgical technologies. Such defensive business qualities minimize the impact of macroeconomic cycles on cash generation.
Who Integra LifeSciences competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Establishment Labs Inc|BBNX: Operating profit EBITDA|Operating profit before amortization IRMD|EMBC (Embecta) - Operating profit EBITDA|Tandem Diabetes Care Inc (TNDM) - Operating income before deduction of amortization|Operating profit EBITDA AXGN|Operating profit before deduction of amortization SI-BONE Medical SIBN|Operating profit EBITDA OFIX (Orthofix Medical Inc.)|Operating profit EBITDA bioventus.com BVS|KIDS - Profit before payment of interest, taxes and amortization|TMCI: Profit before payment of interest, taxes and amortization|SRTA (Strata Critical Medical Corp) - Operating profit before deduction of amortization|Carlsmed Medical - Income before deduction of interest, taxes and amortization|RXST (RxSight, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization ClearPoint CLPT|Profit before payment of interest, taxes and amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Operating profit before depreciation charges|Sight Sciences, Inc - Operating profit before deduction of amortization|Operating profit EBITDA orchestrabiomed.com OBIO|Anika - Operating profit EBITDA|Operating income before deduction of amortization inspiremd.com NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON: Operating profit EBITDA|LFWD - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Autonomix Medical Inc.|Operating profit before amortization IVF (INVO Bioscience)|Operating profit before deduction of amortization BBLG (Bone Biologics Corporation)|Company profit before taxes, interest and amortization AXNX|Operating profit EBITDA BIOL (BIOLASE, Inc.)|Dynatronics Corp (DYNT) - Profit before interest, taxes and amortization|Paragon 28 Corp - Operating profit EBITDA|Operating profit before depreciation charges INVO Bioscience, Inc. (INVO)
